News Center
Another leap! Livzon Pharmaceutical Group's MSCI ESG rating has been upgraded to AA.
Release time:
2022-07-28
Recently, the international authoritative index company MSCI (Morgan Stanley Capital International) announced the latest annual ESG (Environmental, Social and Governance) rating results. With excellent management and performance in ESG for the year 2021, in July 2022, the MSCI ESG rating of Livzon Pharmaceutical Group rose two levels from BBB to AA. Among them, the topics of "product safety and quality" and "pollutant and waste emissions" are at the leading position in the global industry.
The AA rating is currently the highest level in the domestic pharmaceutical industry, placing it among the global industry leaders. This rating upgrade is a high recognition of Livzon Pharmaceutical Group's ESG management achievements and reflects the capital market's full affirmation of Livzon Pharmaceutical Group's sustainable development management performance.
The board of directors of Livzon Pharmaceutical Group attaches great importance to and continuously improves the ESG governance structure and management mechanism. On June 30, 2020, the ESG Committee was established under the board of directors, chaired by the company's chairman, with an ESG working group as its executive body. The ESG Committee is responsible for formulating the company's ESG goals and strategies, monitoring the ESG management structure and operational management, assessing risks and opportunities related to ESG, and continuously consolidating the group's ESG work through the supervision and management of ESG goals.
In 2021, Livzon Pharmaceutical Group launched a multi-level improvement initiative across the entire group, covering various aspects of corporate operational management, including environmental protection, product quality and safety, business ethics, whistleblower protection, supplier quality management, sustainable supply chains, responsible marketing, and inclusive health, thereby comprehensively optimizing the group's governance and sustainable operational capabilities.
In 2021, Livzon Pharmaceutical Group set new carbon reduction targets for 2021-2025 and a carbon neutrality target for 2055, managing climate change risks in reference to TCFD recommendations, guiding the company in fine management of pollutant emissions and resource utilization, achieving a 6.7% year-on-year reduction in greenhouse gas emissions. All production enterprises of the group have obtained ISO 14001 environmental management system certification. The group has also established a system linking ESG performance with management compensation, ensuring the achievement of environmental management goals through effective incentive mechanisms and promoting green and low-carbon operations.
At the same time, Livzon Pharmaceutical Group strives to create a diverse, inclusive, and unbiased friendly working atmosphere, adhering to the core conventions of the International Labour Organization, and has established labor employment and code of conduct guidelines. In 2021, the proportion of female employees in the group was about 48%, with women accounting for 35% of managerial positions and above, and a goal was set for the future to maintain a female employee ratio of no less than 40% and to include at least one female member on the board of directors.
In addition, Livzon Pharmaceutical Group actively gives back to society, with public welfare donations reaching 19.45 million yuan in 2021, having signed 16 agreements for public welfare projects related to chronic disease prevention and control, helping over 5,000 impoverished households, and providing industrial assistance and educational support.
Livzon Pharmaceutical Group always takes "patient quality of life first" as its mission and aims to be a leader in the pharmaceutical industry. While seeking its own sustainable development, it has consistently practiced corporate social responsibility, giving back to society, supporting rural revitalization, and promoting common prosperity. In the future, Livzon Pharmaceutical Group will continue to implement its ESG development strategy, actively promoting the group's sustainable development in areas such as carbon peaking, carbon neutrality, and biodiversity protection.
About MSCI ESG
MSCI is one of the most influential capital market rating agencies globally, and its rating results are the most widely used reference standard by global institutional investors. The ESG rating results of MSCI have become an important basis for decision-making by major investment institutions worldwide. MSCI's ESG ratings cover over 8,500 listed companies, evaluating them based on publicly available information on 35 key ESG issues. The rating results have become an important parameter for corporate governance that major asset management institutions use to make investment decisions, as well as a focus for domestic regulatory agencies and investors.
Related Information